E6/E7 Sequence Diversity of High-Risk Human Papillomaviruses in Two Geographically Isolated Populations of French Guiana.
Maroni
Oyapock
genotype
human papillomavirus
remote populations
variant
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
23 Nov 2020
23 Nov 2020
Historique:
received:
29
09
2020
revised:
18
11
2020
accepted:
19
11
2020
entrez:
26
11
2020
pubmed:
27
11
2020
medline:
27
11
2020
Statut:
epublish
Résumé
Amerindian and Maroon populations of French Guiana have been living in isolation for generations and sexual networks remained mostly endogamous. The present study aimed to describe the phylogeny of E6 and E7 sequences of the most common high-risk HPV genotypes in these regions, to ascertain the diversity of intra-type variants and describe evolutionary relationships. There were 106 women with at least one of HPV16, 18, 31, 52, 58, and 68 genotypes. The most clear-cut phylogenetic pattern was obtained for HPV18 and HPV58 for which the major branches were crisply divided between Amerindian villages on the Oyapock and Maroon villages on the Maroni. Such clustering was less clear for HPV31 and 52. For HPV16, there was also some evidence of clustering on the Oyapock with type A European viruses and on the Maroni with type B and C African viruses among Maroon women. HPV68 showed the largest sequence heterogeneity of the six genotypes at both nucleotide and amino acid levels and was restricted to Maroon women. The present results show that there were significant geographically based differences of E6 and E7 oncogenes. These differences were compatible with different ancestral virus populations and local virus evolution in a context of prolonged population isolation.
Identifiants
pubmed: 33238632
pii: microorganisms8111842
doi: 10.3390/microorganisms8111842
pmc: PMC7700404
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : European Regional Development Fund
ID : Presage number 30814
Références
Epidemiol Infect. 2017 Apr;145(6):1276-1284
pubmed: 28091335
Int J Gynecol Cancer. 2012 Jun;22(5):850-3
pubmed: 22635032
Mol Biol Evol. 2011 Oct;28(10):2731-9
pubmed: 21546353
J Biosci. 2009 Mar;34(1):113-23
pubmed: 19430123
J Natl Cancer Inst. 2001 Sep 5;93(17):1325-30
pubmed: 11535707
Hum Immunol. 2013 Dec;74(12):1610-5
pubmed: 23994586
PLoS One. 2015 Jul 24;10(7):e0133635
pubmed: 26207895
AIDS Care. 2015;27(9):1112-7
pubmed: 25909579
BMC Public Health. 2017 Mar 24;17(1):279
pubmed: 28340612
Int J Gynaecol Obstet. 2014 May;125(2):166-7
pubmed: 24598347
J Med Virol. 2008 Sep;80(9):1639-45
pubmed: 18649325
BMC Womens Health. 2018 Jan 24;18(1):25
pubmed: 29368607
Int J STD AIDS. 2010 May;21(5):359-61
pubmed: 20498108
Cancer Res. 2003 Nov 1;63(21):7215-20
pubmed: 14612516
BMC Public Health. 2017 Jul 17;18(1):23
pubmed: 28716015
PLoS One. 2011;6(5):e20183
pubmed: 21673791
Cad Saude Publica. 2015 Aug;31(8):1615-22
pubmed: 26375641
Genet Mol Res. 2011 Feb 08;10(1):186-96
pubmed: 21341210
J Exp Clin Cancer Res. 2016 Nov 25;35(1):180
pubmed: 27884161
Mem Inst Oswaldo Cruz. 2004 May;99(3):281-2
pubmed: 15273800
Virology. 2013 Oct;445(1-2):232-43
pubmed: 23998342
PLoS One. 2013 Aug 16;8(8):e72565
pubmed: 23977318
Int J STD AIDS. 2015 Jul;26(8):542-8
pubmed: 25080287
Virology. 2011 Feb 5;410(1):201-15
pubmed: 21130481